PhD Toshirou Nishida MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The estimation of recurrence risk remains a critical issue in relation to gastrointestinal stromal tumors (GISTs) treated with adjuvant therapy. The accuracy of the commonly used risk stratifications is not always adequate. For this study, data were prospectively collected from 68 patients with GISTs who underwent R0 surgery between 2004 and 2009. The(More)
  • 1